Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 3:2021:5518717.
doi: 10.1155/2021/5518717. eCollection 2021.

Handcrafted and Deep Learning-Based Radiomic Models Can Distinguish GBM from Brain Metastasis

Affiliations

Handcrafted and Deep Learning-Based Radiomic Models Can Distinguish GBM from Brain Metastasis

Zhiyuan Liu et al. J Oncol. .

Abstract

Objective: The purpose of this study was to investigate the feasibility of applying handcrafted radiomics (HCR) and deep learning-based radiomics (DLR) for the accurate preoperative classification of glioblastoma (GBM) and solitary brain metastasis (BM).

Methods: A retrospective analysis of the magnetic resonance imaging (MRI) data of 140 patients (110 in the training dataset and 30 in the test dataset) with GBM and 128 patients (98 in the training dataset and 30 in the test dataset) with BM confirmed by surgical pathology was performed. The regions of interest (ROIs) on T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), and contrast-enhanced T1WI (T1CE) were drawn manually, and then, HCR and DLR analyses were performed. On this basis, different machine learning algorithms were implemented and compared to find the optimal modeling method. The final classifiers were identified and validated for different MRI modalities using HCR features and HCR + DLR features. By analyzing the receiver operating characteristic (ROC) curve, the area under the curve (AUC), accuracy, sensitivity, and specificity were calculated to evaluate the predictive efficacy of different methods.

Results: In multiclassifier modeling, random forest modeling showed the best distinguishing performance among all MRI modalities. HCR models already showed good results for distinguishing between the two types of brain tumors in the test dataset (T1WI, AUC = 0.86; T2WI, AUC = 0.76; T1CE, AUC = 0.93). By adding DLR features, all AUCs showed significant improvement (T1WI, AUC = 0.87; T2WI, AUC = 0.80; T1CE, AUC = 0.97; p < 0.05). The T1CE-based radiomic model showed the best classification performance (AUC = 0.99 in the training dataset and AUC = 0.97 in the test dataset), surpassing the other MRI modalities (p < 0.05). The multimodality radiomic model also showed robust performance (AUC = 1 in the training dataset and AUC = 0.84 in the test dataset).

Conclusion: Machine learning models using MRI radiomic features can help distinguish GBM from BM effectively, especially the combination of HCR and DLR features.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Study workflow overview.
Figure 2
Figure 2
The Boruta selection of HCR + DLR features of T1CE data. Green and yellow indicate high-importance features, and blue and red indicate low-importance features.
Figure 3
Figure 3
Performance of different machine learning modeling methods in 6 feature groups. (a)–(c) ROC curves of the HCR models based on T1CE, T1WI, and T2WI data, respectively. (d)–(f) ROC curves of the HCR + DLR models based on T1CE, T1WI, and T2WI data, respectively.
Figure 4
Figure 4
Diagnostic performance of 6 feature groups. (a)-(b) ROC curves of the HCR model based on T1CE data in the training dataset and test dataset, respectively. (c)-(d) HCR + DLR models of T1CE data in the training and test datasets. (e)–(h) HCR and HCR + DLR models of T1WI data in the training dataset and test dataset. (i)–(l) Details of T2WI data.
Figure 5
Figure 5
ROC curves of the multimodality radiomic model. (a) Results of 10-fold cross-validation in the training dataset. (b) Comparison of different machine learning models. (c) Final multimodality model in the training dataset. (d) Final multimodality model in the test dataset.

References

    1. Fox B. D., Cheung V. J., Patel A. J., Suki D., Rao G. Epidemiology of metastatic brain tumors. Neurosurgery Clinics of North America. 2011;22(1):1–6. doi: 10.1016/j.nec.2010.08.007. - DOI - PubMed
    1. Ostrom Q. T., Cioffi G., Gittleman H., et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016. Neuro-Oncology. 2019;21 doi: 10.1093/neuonc/noz150. - DOI - PMC - PubMed
    1. Adamson C., Kanu O. O., Mehta A. I., et al. Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opinion on Investigational Drugs. 2009;18(8):1061–1083. doi: 10.1517/13543780903052764. - DOI - PubMed
    1. Sundström J. T., Minn H., Lertola K. K., Nordman E. Prognosis of patients treated for intracranial metastases with whole-brain irradiation. Annals of Medicine. 1998;30(3):296–299. doi: 10.3109/07853899809005858. - DOI - PubMed
    1. Stupp R., Mason W. P., van den Bent M. J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England Journal of Medicine. 2005;352(10):987–996. doi: 10.1056/NEJMoa043330. - DOI - PubMed

LinkOut - more resources